IL-6, a pro-inflammatory cytokine produced by both cardiomyocytes and fibroblasts [23, 52], is increased in post-MI patients [22] and elevated in patients with heart failure [24], where it correlates with increased risk of cardiovascular events and ventricular dysfunction [24, 53]. This evidence concerns the gene IL6 and heart failure.